Harmony Biosciences
HRMY
HRMY
210 hedge funds and large institutions have $1.83B invested in Harmony Biosciences in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 85 increasing their positions, 65 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 216 → 210 (-6)
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
52% less call options, than puts
Call options by funds: $4.37M | Put options by funds: $9.12M
Holders
210
Holding in Top 10
7
Calls
$4.37M
Puts
$9.12M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$27.8M | |
| 3 | +$15.4M | |
| 4 |
Man Group
London,
United Kingdom
|
+$11.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.47M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$19.5M | |
| 3 | -$9.85M | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$9.25M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.57M |